15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Biodesix Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $27.00 to $35.00, so the covering firms are broadly aligned. The average target of $31.33 sits 17% above the current $26.77. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 25% this year and 20% next, consensus EPS building from about $-0.43 next quarter toward $-1.67 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Strong Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Biodesix Inc.
As of Sep, 4 of 4 firms rate BDSX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BDSX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.43
Range $-0.51 – $-0.37 · 7 analysts · -13% YoY
Next period, 7 analysts expect Biodesix Inc to earn $-0.43 a share (range $-0.51 – $-0.37), versus $-0.49 a year earlier. Full-year consensus is $-2.67, growing to $-1.67 the year after.
REVENUE · NEXT QUARTER
$32.0M
Range $31.5M – $32.8M · 7 analysts · +27% YoY
Revenue is expected to reach $32.0M (range $31.5M – $32.8M), +27.0% year-over-year. Full-year consensus is $112.0M, rising to $134.6M next year.
Top analysts covering Biodesix Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BDSX.
#1
SJ
Sung Ji Nam
Scotiabank · Rank #140
Buy
$2.00-92.5% to target
Overall win rate
46%
+ Follow
#2
TF
Thomas Flaten
Lake Street · Rank #238
Buy
$40.00+49.4% to target
Overall win rate
40%
+ Follow
#3
KM
Kyle Mikson
Canaccord Genuity · Rank #263
Buy
$35.00+30.7% to target
Overall win rate
34%
+ Follow
#4
Yi Chen
HC Wainwright & Co. · Rank #277
Buy
$27.00+0.9% to target
Overall win rate
33%
+ Follow
#5
Daniel Brennan
TD Cowen
Buy
$30.00+12.1% to target
Coverage
—
+ Follow
BDSX stock forecast FAQ
What is BDSX's average 12-month price target?+
The 3 analysts with a live target average $31.33 for Biodesix Inc over the next 12 months, ranging from a $35.00 high to a $27.00 low.
Is BDSX stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BDSX?+
The Street-high target is $35.00 (Canaccord Genuity), and the Street-low is $27.00 (HC Wainwright & Co.). The average of all 3 active targets is $31.33.
How many Wall Street analysts cover BDSX?+
4 analysts have an active rating on Biodesix Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering BDSX?+
Among analysts who currently cover BDSX, Sung Ji Nam of Scotiabank has the strongest overall Quantellect track record (Rank #140). Their current call is Buy with a $2.00 target.
What is Biodesix Inc's projected EPS for next quarter?+
The consensus estimate is $-0.43 per share (range $-0.51 – $-0.37) across 7 analysts. Full-year EPS is projected at $-2.67, rising to $-1.67 the following year.
How much revenue is Biodesix Inc expected to report next quarter?+
Consensus revenue is $32.0M (range $31.5M – $32.8M). Full-year revenue is projected at $112.0M, growing to $134.6M next year.
Have analysts been upgrading or downgrading BDSX lately?+
As of Sep, 4 of 4 firms rate BDSX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BDSX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
